Athira Pharma Inc (NASDAQ:ATHA)

Delayed Data
As of Nov 25
 -0.03 / -0.99%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Athira Pharma Inc have a median target of 5.50, with a high estimate of 33.00 and a low estimate of 3.00. The median estimate represents a +83.33% increase from the last price of 3.00.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Athira Pharma Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.40%
Growthannually -61.43%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.